课题基金 / 基金详情

项目摘要

项目成果

Brian L Black的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):先天性心脏缺陷影响了近1%的活产婴儿,是美国婴儿死亡的最常见原因。最严重的先天性心脏病形式是涉及流出道和室间隔的先天性心脏病,而瓣膜异常是最常见的先天性心脏病形式。拟议研究的长期目标是确定控制心血管发育的分子机制和途径,并强调这些先天性心脏异常。具体而言,本申请集中于识别在第二心脏领域(SHF)及其在OFT和RV中的衍生物的发育期间起作用的转录途径和机制。LIM-homeodomain转录因子Isl 1和MADS结构域转录因子MEF 2C是SHF发展的重要调节因子。最近的工作已经确定Mef 2c基因是SHF中Isl 1的直接转录靶点,形成了AHF中转录途径的基础。然而,上游转录调控因子的Isl 1基因在SHF仍然不确定,尽管早期,Isl 1在该谱系中的重要作用。类似地,MEF 2C的下游靶点尚不清楚,尽管Mef 2c是心脏发育所需的,并且其功能在SHF中是特别需要的,用于适当的OFT对齐和内膜垫重塑。因此,该提议将检验以下假设:在SHF中需要MEF 2C来控制细胞数量或SHF衍生的细胞迁移到OFT内皮细胞垫中,并且MEF 2C是内皮细胞垫中Nfatc 1的直接转录激活因子。这是重要的,因为转录因子NFATc 1是内膜垫重塑和心脏瓣膜成熟所必需的。该提案还将测试的假设,即在SHF的Isl 1基因的表达是通过一种新的模块化增强子,整合上游信号直接表达在心血管祖细胞的前外侧中胚层的调节。提出了两个具体目标。具体目标之一是通过在小鼠中使用条件性敲除方法检查Mef 2c对SHF衍生细胞迁移到心脏以及细胞增殖和存活的需求,确定OFT对齐和心内膜垫发育中对MEF 2C的需求。Specific Aim 1还将使用转基因小鼠方法,通过Nfatc 1内皮细胞特异性增强子中存在的保守共有MEF 2位点,确定Nfatc 1是否是流出道内皮细胞垫中MEF 2C的直接转录靶标。具体目标2将通过定义一种新的SHF特异性Isl 1转录增强子的上游调节子来确定SHF中Isl 1转录的调节子。我们的目标是将Isl 1置于转录和信号通路中,这将提供有关控制心脏发育和Isl 1+祖细胞自我更新和分化的早期事件的重要信息。 公共卫生相关性:心脏缺陷是美国最常见的出生缺陷,影响近1%的新生儿。这些缺陷中最严重的是紫绀病变,其影响心室和流出道的分隔,并允许含氧和脱氧血液混合。拟议的研究将有助于了解控制心脏发育的分子途径以及生化和遗传机制。定义这些途径对于确定如何重新激活控制心脏组织发育的遗传程序以用于再生和修复、组织工程、诱导多能细胞的定向分化以及心血管出生缺陷的诊断和干预至关重要。
英文摘要
DESCRIPTION (provided by applicant): Congenital cardiac defects affect nearly 1% of all live births and are the most common cause of infant mortality in the United States. Among the most severe forms of congenital heart defects are those involved in outflow tract and interventricular septation, whereas valve anomalies are the most common form of congenital heart defect. The long-term goal of the proposed studies is to define the molecular mechanisms and pathways that control cardiovascular development and underscore these congenital cardiac anomalies. Specifically, this application is focused on the identification of transcriptional pathways and mechanisms that function during the development of the second heart field (SHF) and its derivatives in the OFT and RV. The LIM-homeodomain transcription factor Isl1 and the MADS domain transcription factor MEF2C are essential regulators of SHF development. Recent work has established that the Mef2c gene is a direct transcriptional target of Isl1 in the SHF, forming the basis of a transcriptional pathway in the AHF. However, the upstream transcriptional regulators of the Isl1 gene in the SHF remain undefined in spite of the early, essential role for Isl1 in that lineage. Similarly, the downstream targets of MEF2C are not known, even though Mef2c is required for heart development, and its function is required specifically in the SHF for proper OFT alignment and endocardial cushion remodeling. This proposal will therefore test the hypothesis that MEF2C is required in the SHF to control cell number or migration of SHF-derived cells into the OFT endocardial cushions and that MEF2C is a direct transcriptional activator of Nfatc1 in the endocardial cushions. This is significant since the transcription factor NFATc1 is required for endocardial cushion remodeling and heart valve maturation. This proposal will also test the hypothesis that the expression of the Isl1 gene in the SHF is regulated via a novel modular enhancer that integrates upstream signals to direct expression in cardiovascular progenitors in the anterior lateral mesoderm. Two specific aims are proposed. Specific aim one will determine the requirement of MEF2C in OFT alignment and endocardial cushion development by examining the requirement of Mef2c for migration of SHF-derived cells into the heart and for cell proliferation and survival using a conditional knockout approach in mice. Specific Aim 1 will also determine if Nfatc1 is a direct transcriptional target of MEF2C in the outflow tract endocardial cushions via a conserved, consensus MEF2 site present in the Nfatc1 endocardial- specific enhancer using a transgenic mouse approach. Specific Aim 2 will identify regulators of Isl1 transcription in the SHF by defining upstream regulators of a novel SHF-specific Isl1 transcriptional enhancer. The goal is to place Isl1 into a transcriptional and signaling pathway, which will provide essential information about the early events controlling heart development and Isl1+ progenitor self-renewal and differentiation. PUBLIC HEALTH RELEVANCE: Heart defects are the most common class of birth defect in the United States, affecting nearly 1% of all newborns. Among the most serious of these defects are the cyanotic lesions, which affect septation of the ventricles and outflow tracts and allow oxygenated and deoxygenated blood to mix. The proposed studies will contribute to the understanding of the molecular pathways and the biochemical and genetic mechanisms controlling heart development. Defining these pathways is essential to determine how to reactivate the genetic programs controlling the development of heart tissue for the purpose of regeneration and repair, tissue engineering, directed differentiation of induced pluripotent cells, and diagnosis and intervention in cardiovascular birth defects.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Project 3: Control of cardiac transcription by MEF2 and myocardin
  • 批准号:
    10471991
  • 项目类别:
  • 资助金额:
    $50.91万
  • 财政年份:
    2019
  • 负责人:
    Brian L Black
  • 依托单位:
Project 3: Control of cardiac transcription by MEF2 and myocardin
  • 批准号:
    10006190
  • 项目类别:
  • 资助金额:
    $51.63万
  • 财政年份:
    2019
  • 负责人:
    Brian L Black
  • 依托单位:
Project 3: Control of cardiac transcription by MEF2 and myocardin
  • 批准号:
    10245031
  • 项目类别:
  • 资助金额:
    $51.71万
  • 财政年份:
    2019
  • 负责人:
    Brian L Black
  • 依托单位:
NAVBO Workshops at Vascular Biology 2017
海外基金